Menotracker wants to fix menopause symptom tracking — without selling user data

**Menotracker Pioneers Data-Privacy-First Approach to Menopause Symptom Management** Menotracker, an innovative AI-powered application focused on menopause symptom tracking, has launched with a significant emphasis on user data privacy, partnering with ConsentKeys to become the first women's health application that will not store personal user data. This development addresses a critical concern in the digital health sector, where the exploitation of sensitive health information has become increasingly prevalent, offering users a secure alternative for managing their perimenopause and menopause symptoms. The app transforms complex symptoms into personalized insights and actionable support, a stark contrast to many existing health trackers that prioritize data monetization over user well-being. By allowing users to track symptoms, integrate wearable device data, and generate correlation reports, Menotracker empowers individuals to take ownership of their health journeys and present structured data to clinicians, potentially reducing instances of medical gaslighting and improving diagnostic accuracy. This privacy-centric approach is particularly relevant in the European context, where robust data protection regulations like GDPR set a high bar for digital services. Menotracker's model, which aligns with European values of digital sovereignty and individual control over personal data, offers a model for how femtech companies can innovate responsibly. The company's commitment to diversity in research, aiming to build more representative datasets, further enhances its appeal and potential impact.